GOOD JENNIFER L
Insider CIK 1229245 · TRVI See Remarks, Director, 10% owner · RYTM Director · JNP Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2026-06-24 | 2026-06-25 | 3,691 | — | $0 | 3,691 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2026-06-24 | 2026-06-25 | 2,324 | — | $0 | 2,324 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2026-06-23 | 2026-06-25 | 4,712 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2026-06-23 | 2026-06-25 | 4,712 | — | $0 | 11,712 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2026-02-19 | 2026-02-20 | 675,000 | — | $0 | 675,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2025-06-24 | 2025-06-26 | 4,712 | — | $0 | 4,712 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2025-06-24 | 2025-06-26 | 7,037 | — | $0 | 7,037 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2025-06-18 | 2025-06-23 | 4,000 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2025-06-18 | 2025-06-23 | 4,000 | — | $0 | 7,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-05-31 | 2025-06-03 | 102,000 | — | $0 | 156,400 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2025-03-21 | 2025-03-25 | 5,263 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2025-03-21 | 2025-03-25 | 5,263 | $6.58 | $34.6K | 213,313 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2025-03-21 | 2025-03-25 | 5,263 | $1.43 | $7.5K | 218,576 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-03-10 | 2025-03-12 | 54,400 | — | $0 | 54,400 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-02-18 | 2025-02-20 | 811,000 | — | $0 | 811,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-09-17 | 2024-09-19 | 15,000 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-09-17 | 2024-09-19 | 7,501 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-09-17 | 2024-09-19 | 9,250 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-09-17 | 2024-09-19 | 7,501 | $18.99 | $142.4K | 34,751 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-09-17 | 2024-09-19 | 9,250 | $21.37 | $197.7K | 27,250 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-09-17 | 2024-09-19 | 15,000 | $22.93 | $343.9K | 18,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2024-09-17 | 2024-09-19 | 31,751 | $52.40 | $1.66M | 3,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2024-09-09 | 2024-09-09 | 1,840 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-09-09 | 2024-09-11 | 12,900 | — | $0 | 15,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-09-09 | 2024-09-11 | 1,736 | — | $0 | 7,501 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-09-09 | 2024-09-11 | 4,305 | — | $0 | 9,250 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-09-09 | 2024-09-11 | 18,300 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2024-09-09 | 2024-09-09 | 1,840 | $3.04 | $5.6K | 213,313 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2024-09-09 | 2024-09-09 | 1,840 | $1.43 | $2.6K | 215,153 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-09-09 | 2024-09-11 | 18,300 | $4.15 | $75.9K | 40,241 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2024-09-09 | 2024-09-11 | 37,241 | $50.45 | $1.88M | 3,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-09-09 | 2024-09-11 | 12,900 | $22.93 | $295.8K | 15,900 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-09-09 | 2024-09-11 | 4,305 | $21.37 | $92.0K | 20,205 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-09-09 | 2024-09-11 | 1,736 | $18.99 | $33.0K | 21,941 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2024-09-06 | 2024-09-09 | 4,219 | — | $0 | 1,840 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2024-09-06 | 2024-09-09 | 4,219 | $3.03 | $12.8K | 213,313 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2024-09-06 | 2024-09-09 | 4,219 | $1.43 | $6.0K | 217,532 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2024-09-05 | 2024-09-05 | 40,277 | — | $0 | 6,059 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2024-09-05 | 2024-09-05 | 40,277 | $1.43 | $57.6K | 253,590 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2024-09-05 | 2024-09-05 | 40,277 | $3.11 | $125.3K | 213,313 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2024-09-04 | 2024-09-05 | 10,981 | — | $0 | 46,336 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2024-09-04 | 2024-09-05 | 10,981 | $1.43 | $15.7K | 224,294 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2024-09-04 | 2024-09-05 | 10,981 | $3.02 | $33.2K | 213,313 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2024-09-03 | 2024-09-05 | 3,863 | — | $0 | 57,317 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2024-09-03 | 2024-09-05 | 3,863 | $1.43 | $5.5K | 217,176 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 3,863 | $3.02 | $11.7K | 213,313 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-08-26 | 2024-08-28 | 1,700 | — | $0 | 18,300 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-08-26 | 2024-08-28 | 5,763 | — | $0 | 9,237 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-08-26 | 2024-08-28 | 2,100 | — | $0 | 27,900 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-08-26 | 2024-08-28 | 4,945 | — | $0 | 13,555 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2024-08-26 | 2024-08-28 | 14,508 | $50.01 | $725.5K | 3,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-08-26 | 2024-08-28 | 1,700 | $4.15 | $7.1K | 17,508 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-08-26 | 2024-08-28 | 5,763 | $18.99 | $109.4K | 15,808 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-08-26 | 2024-08-28 | 4,945 | $21.37 | $105.7K | 10,045 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-08-26 | 2024-08-28 | 2,100 | $22.93 | $48.2K | 5,100 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-06-21 | 2024-06-25 | 3,000 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-06-21 | 2024-06-25 | 3,000 | — | $0 | 3,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2024-06-18 | 2024-06-20 | 4,000 | — | $0 | 4,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2024-06-18 | 2024-06-20 | 14,000 | — | $0 | 14,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2024-05-20 | 2024-05-22 | 25,037 | — | $0 | 33,189 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2024-05-20 | 2024-05-22 | 25,037 | $2.86 | $71.6K | 213,313 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2024-05-20 | 2024-05-22 | 25,037 | $2.19 | $54.8K | 238,350 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2024-05-10 | 2024-05-14 | 4,578 | — | $0 | 58,226 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2024-05-10 | 2024-05-14 | 4,578 | $2.19 | $10.0K | 217,891 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2024-05-10 | 2024-05-14 | 4,578 | $2.90 | $13.3K | 213,313 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2024-02-15 | 2024-02-16 | 630,000 | — | $0 | 630,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2023-06-21 | 2023-06-23 | 3,000 | — | $0 | 3,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2023-06-21 | 2023-06-23 | 14,000 | — | $0 | 14,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2023-02-16 | 2023-02-16 | 375,000 | — | $0 | 375,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-09-19 | 2022-09-19 | 32,000 | — | $0 | 160,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-06-29 | 2022-07-01 | 128,000 | — | $0 | 128,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2022-06-08 | 2022-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-02-14 | 2022-07-01 | 275,000 | — | $0 | 275,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-02-14 | 2022-02-15 | 275,000 | — | $0 | 275,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2021-06-09 | 2021-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2021-02-17 | 2021-02-19 | 160,000 | — | $0 | 160,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2020-06-17 | 2020-06-18 | 18,500 | — | $0 | 18,500 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2020-02-13 | 2020-02-18 | 200,000 | — | $0 | 200,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2019-06-19 | 2019-06-21 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2019-06-03 | 2019-06-05 | 310,000 | — | $0 | 310,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 109,015 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 23,947 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2019-05-09 | 2019-05-13 | 11,250 | $10.00 | $112.5K | 206,204 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion | 2019-05-09 | 2019-05-13 | 18,348 | — | $0 | 194,954 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | D To issuer | 2018-08-14 | 2018-08-15 | 15,000 | $11.50 | $172.5K | 0 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | A Award | 2017-09-07 | 2017-09-11 | 15,000 | — | $0 | 15,000 | SEC↗ |